Company patents
Owen Mumford Limited
Owen Mumford Limited's patent strategy is heavily concentrated in Drug Delivery Devices, representing 67.9% of its portfolio, yet this core area saw a significant 62.5% decline in patenting from 2024 to 2025. Surprisingly, while Medical Diagnostics & Surgery experienced a rapid 200.0% growth in 2025, it has seen a complete halt in patenting so far in 2026, suggesting a potentially shifting focus despite the previous year's surge.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
53 US filings (since 2023) · 3 categories · 5 themes
Mechanical or electromechanical systems designed for precise, often self-administered, delivery of medicaments, including features for dose setting, needle insertion/retraction, and safety mechanisms to prevent premature activation.
Self-contained or modular devices designed to automate and integrate multiple steps of molecular diagnostic assays, from sample preparation to result interpretation, often for point-of-care or high-throughput applications.
Miniaturized devices that manipulate small volumes of fluids (nanoliters to picoliters) through microchannels to perform laboratory functions like mixing, separation, reaction, and detection on a single chip.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Patents
Showing 1-10 of 118